{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:14:56Z","timestamp":1761178496902,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.canrad.2016.05.013","type":"journal-article","created":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T07:39:57Z","timestamp":1467445197000},"page":"384-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic significance of Livin expression in nasopharyngeal carcinoma after radiotherapy"],"prefix":"10.1016","volume":"20","author":[{"given":"A.-H.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-B.","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.-X.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.-L.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.-G.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2016.05.013_bib0005","doi-asserted-by":"crossref","first-page":"762128","DOI":"10.1155\/2015\/762128","article-title":"Omics-based identification of biomarkers for nasopharyngeal carcinoma","volume":"2015","author":"Janvilisri","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.canrad.2016.05.013_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jprot.2013.03.001","article-title":"Quantitative proteome analysis of overexpressed Cripto-1 tumor cell reveals 14-3-3gamma as a novel biomarker in nasopharyngeal carcinoma","volume":"83","author":"Wu","year":"2013","journal-title":"J Proteomic"},{"key":"10.1016\/j.canrad.2016.05.013_bib0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.oraloncology.2012.09.016","article-title":"Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology","volume":"49","author":"Arnold","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s13277-013-1047-x","article-title":"Meta-analysis of the association between GSTT1 null genotype and risk of nasopharyngeal carcinoma in Chinese","volume":"35","author":"Jin","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0025","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1007\/s13277-013-1416-5","article-title":"EMP1 inhibits nasopharyngeal cancer cell growth and metastasis through induction apoptosis and angiogenesis","volume":"35","author":"Sun","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0030","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.ejca.2010.04.004","article-title":"Nasopharyngeal carcinoma: the next challenges","volume":"46","author":"Razak","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2016.05.013_bib0035","first-page":"950","article-title":"MMP14 regulates cell migration and invasion through epithelial-mesenchymal transition in nasopharyngeal carcinoma","volume":"7","author":"Yan","year":"2015","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.canrad.2016.05.013_bib0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1399-0039.2011.01702.x","article-title":"Association of IL-12p40+1188 A\/C polymorphism with nasopharyngeal cancer risk and tumor extension","volume":"78","author":"Ben Chaaben","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.canrad.2016.05.013_bib0045","doi-asserted-by":"crossref","first-page":"689048","DOI":"10.1155\/2013\/689048","article-title":"Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a meta-analysis","volume":"2013","author":"Li","year":"2013","journal-title":"Sci World J"},{"key":"10.1016\/j.canrad.2016.05.013_bib0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcancer.2012.01.007","article-title":"Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000\u20132011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors","volume":"22","author":"Hildesheim","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0055","first-page":"1575","article-title":"[Progress of treating nasopharyngeal carcinoma by Chinese pharmacy and radiotherapy]","volume":"33","author":"Huang","year":"2013","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.1016\/j.canrad.2016.05.013_bib0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semradonc.2012.03.008","article-title":"Current management of nasopharyngeal cancer","volume":"22","author":"Lee","year":"2012","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0065","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1038\/cddis.2010.64","article-title":"Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98","volume":"1","author":"Alajez","year":"2010","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.canrad.2016.05.013_bib0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13014-015-0443-3","article-title":"Evaluation of effect of body mass index and weight loss on survival of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy","volume":"10","author":"Lin","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yexmp.2013.05.006","article-title":"Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma","volume":"95","author":"Lee","year":"2013","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0080","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ceb.2010.08.025","article-title":"To fight or die \u2013\u00a0inhibitor of apoptosis proteins at the crossroad of innate immunity and death","volume":"22","author":"Lopez","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.canlet.2010.06.013","article-title":"Antagonists of IAP proteins as cancer therapeutics","volume":"332","author":"Dynek","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canrad.2016.05.013_bib0090","first-page":"200","article-title":"The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy","volume":"34","author":"de Almagro","year":"2012","journal-title":"Exp Oncol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0095","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.cellsig.2013.03.012","article-title":"Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling","volume":"25","author":"Li","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.canrad.2016.05.013_bib0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s13277-012-0596-8","article-title":"Upregulation of the anti-apoptotic factor Livin contributes to cisplatin resistance in colon cancer cells","volume":"34","author":"Ding","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3892\/ijo.2013.2171","article-title":"Knockdown of Livin inhibits growth and invasion of gastric cancer cells through blockade of the MAPK pathway in vitro and in vivo","volume":"44","author":"Ou","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0110","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ejca.2012.08.029","article-title":"Livin expression may be regulated by miR-198 in human prostate cancer cell lines","volume":"49","author":"Ye","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2016.05.013_bib0115","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1155\/2013\/781740","article-title":"Expression and clinical significance of livin protein in hepatocellular carcinoma","volume":"35","author":"Guo","year":"2013","journal-title":"Dis Markers"},{"key":"10.1016\/j.canrad.2016.05.013_bib0120","doi-asserted-by":"crossref","first-page":"e73262","DOI":"10.1371\/journal.pone.0073262","article-title":"Expression of Livin in colorectal cancer and its relationship to tumor cell behavior and prognosis","volume":"8","author":"Myung","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canrad.2016.05.013_bib0125","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/jso.23272","article-title":"Expression of survivin and livin predicts early recurrence in non-muscle invasive bladder cancer","volume":"107","author":"Xi","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/PAI.0b013e31827da412","article-title":"Expression and prognostic significance of livin, caspase-3, and ki-67 in the progression of human ampullary carcinoma","volume":"21","author":"Xue","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0135","first-page":"585","article-title":"Role of inhibitor of apoptosis protein Livin in radiation resistance in non-small cell lung cancer","volume":"26","author":"Sun","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.canrad.2016.05.013_bib0140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/cncr.29795","article-title":"Proposal for the 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy","volume":"122","author":"Pan","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2016.05.013_bib0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00432-007-0276-z","article-title":"Livin and Bcl-2 expression in high-grade osteosarcoma","volume":"134","author":"Nedelcu","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2016.05.013_bib0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20100814","article-title":"Survivin and IAP proteins in cell-death mechanisms","volume":"430","author":"Altieri","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.canrad.2016.05.013_bib0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/cells2010163","article-title":"Regulation of apoptosis by inhibitors of apoptosis (IAPs)","volume":"2","author":"Berthelet","year":"2013","journal-title":"Cells"},{"key":"10.1016\/j.canrad.2016.05.013_bib0165","doi-asserted-by":"crossref","first-page":"28445","DOI":"10.1074\/jbc.M112.341297","article-title":"Role of melanoma inhibitor of apoptosis (ML-IAP) protein, a member of the baculoviral IAP repeat (BIR) domain family, in the regulation of C-RAF kinase and cell migration","volume":"287","author":"Oberoi-Khanuja","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.canrad.2016.05.013_bib0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-011-0873-7","article-title":"Research progress on Livin protein: an inhibitor of apoptosis","volume":"357","author":"Yan","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.canrad.2016.05.013_bib0175","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/sj.cdd.4401959","article-title":"Livin promotes Smac\/DIABLO degradation by ubiquitin-proteasome pathway","volume":"13","author":"Ma","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.canrad.2016.05.013_bib0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000334234","article-title":"The clinical effect of the inhibitor of apopotosis protein livin in melanoma","volume":"82","author":"Lazar","year":"2012","journal-title":"Oncology"},{"key":"10.1016\/j.canrad.2016.05.013_bib0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.urolonc.2008.03.015","article-title":"Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment","volume":"27","author":"Liu","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0190","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1158\/0008-5472.CAN-09-0424","article-title":"The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity","volume":"69","author":"Abd-Elrahman","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.canrad.2016.05.013_bib0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.mlg.0000187392.87904.35","article-title":"Prognostic value of Survivin and Livin in nasopharyngeal carcinoma","volume":"116","author":"Xiang","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2016.05.013_bib0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1748-717X-8-281","article-title":"Livin expression is an independent factor in rectal cancer patients with or without preoperative radiotherapy","volume":"8","author":"Ding","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2016.05.013_bib0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbrc.2010.08.001","article-title":"Expression and functional role of inhibitor-of-apoptosis protein livin (BIRC7) in neuroblastoma","volume":"400","author":"Dasgupta","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.canrad.2016.05.013_bib0210","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3892\/or.2013.2724","article-title":"Expression and prognostic significance of Livin in gastric cancer","volume":"30","author":"Chung","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.canrad.2016.05.013_bib0215","first-page":"903","article-title":"Inhibition of tumorigenesis and invasion of hepatocellular carcinoma by siRNA-mediated silencing of the livin gene","volume":"3","author":"Liu","year":"2010","journal-title":"Mol Med Rep"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321816300968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321816300968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:24:41Z","timestamp":1761135881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321816300968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1278321816300968"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2016.05.013","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of Livin expression in nasopharyngeal carcinoma after radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2016.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}